Skip to main content

BioWisdom to Market Connexor Text Analyzer with its Sofia Platform

NEW YORK (GenomeWeb News) - Text analysis software company Connexor said on Friday that BioWisdom will distribute its Machinese platform along with its own Sofia Knowledge Suite.
Machinese will be used in BioWisdom's sofiaEditor module to automatically extract information from text-based online literature, Connexor said.
BioWisdom uses the Sofia suite to create so-called Intelligence Networks, which “allow unbiased, systematic analysis of problems and are used to support decision-making in all areas of the healthcare industry.”
Connexor said Machinese speeds up product development by "reducing the need for costly manual extraction and enabling timely discovery of facts and trends."
Financial terms of the deal were not disclosed.
BioWisdom also has an ongoing partnership with drugmaker AstraZeneca.

Filed under

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.